Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamid Emamekhoo

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Cancer|December 25, 2018
Are liquid biopsies ready for primetime?Hamid Emamekhoo, Joshua M Lang
Cell Cycle (Georgetown, Tex.)|August 28, 2015
Clinical significance of D4A in prostate cancer therapy with abirateroneHamid Emamekhoo, Zhenfei Li, Nima Sharifi
Cancer|December 7, 2021
Providing cessation treatment to every oncology patient who smokes: An essential component of cancer careMichael C Fiore, Timothy B Baker, Margaret B Nolan, et al.
Frontiers in Oncology|May 11, 2023
PARP inhibitors in metastatic prostate cancerAmy K Taylor, David Kosoff, Hamid Emamekhoo, et al.
Urology Case Reports|June 7, 2021
A case of metastatic renal cell carcinoma with concomitant Castleman's disease treated with immunotherapyTaja Lozar, Matthew J Brunner, Sujal I Shah, et al.
Biomedical Physics & Engineering Express|September 17, 2021
Image intensity histograms as imaging biomarkers: application to immune-related colitisDaniel T Huff, Peter Ferjancic, Mauro Namías, et al.
Anticancer Research|March 6, 2020
Polycystic Liver Disease in a Patient With Metastatic Renal Cell Carcinoma: A Case ReportLucas Zarling, Hamid Emamekhoo, Gauri Bhutani, et al.
BMC Biotechnology|February 11, 2010
Comparative transfection of DNA into primary and transformed mammalian cells from different lineagesRosalie Maurisse, David De Semir, Hamid Emamekhoo, et al.
Clinical Genitourinary Cancer|September 22, 2018
Evaluation of Response to Enzalutamide Consecutively After Abiraterone Acetate/Prednisone Failure in Patients With Metastatic Castration-resistant Prostate CancerHamid Emamekhoo, Pedro C Barata, Natasha C Edwin, et al.
Pigment Cell & Melanoma Research|October 30, 2023
Neutrophil-to-eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti-PD-1 therapyVincent Pozorski, Yeonhee Park, Yusuf Mohamoud, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Cancer|December 25, 2018
Are liquid biopsies ready for primetime?Hamid Emamekhoo, Joshua M Lang
Cell Cycle (Georgetown, Tex.)|August 28, 2015
Clinical significance of D4A in prostate cancer therapy with abirateroneHamid Emamekhoo, Zhenfei Li, Nima Sharifi
Cancer|December 7, 2021
Providing cessation treatment to every oncology patient who smokes: An essential component of cancer careMichael C Fiore, Timothy B Baker, Margaret B Nolan, et al.
Frontiers in Oncology|May 11, 2023
PARP inhibitors in metastatic prostate cancerAmy K Taylor, David Kosoff, Hamid Emamekhoo, et al.
Urology Case Reports|June 7, 2021
A case of metastatic renal cell carcinoma with concomitant Castleman's disease treated with immunotherapyTaja Lozar, Matthew J Brunner, Sujal I Shah, et al.
Biomedical Physics & Engineering Express|September 17, 2021
Image intensity histograms as imaging biomarkers: application to immune-related colitisDaniel T Huff, Peter Ferjancic, Mauro Namías, et al.
Anticancer Research|March 6, 2020
Polycystic Liver Disease in a Patient With Metastatic Renal Cell Carcinoma: A Case ReportLucas Zarling, Hamid Emamekhoo, Gauri Bhutani, et al.
BMC Biotechnology|February 11, 2010
Comparative transfection of DNA into primary and transformed mammalian cells from different lineagesRosalie Maurisse, David De Semir, Hamid Emamekhoo, et al.
Clinical Genitourinary Cancer|September 22, 2018
Evaluation of Response to Enzalutamide Consecutively After Abiraterone Acetate/Prednisone Failure in Patients With Metastatic Castration-resistant Prostate CancerHamid Emamekhoo, Pedro C Barata, Natasha C Edwin, et al.
Pigment Cell & Melanoma Research|October 30, 2023
Neutrophil-to-eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti-PD-1 therapyVincent Pozorski, Yeonhee Park, Yusuf Mohamoud, et al.
Pageof 7